Every Form 4 that Oscar Health, Inc. (OSCR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow OSCR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OSCR filings page.
Oscar Health, Inc. reported an insider stock sale by a person who is both a director and the company’s President of Technology & CTO. On 12/24/2025, this insider sold 38,835 shares of Class A common stock in an open-market transaction. The sale is coded as a disposition and left the insider with 438,348 shares beneficially owned directly.
The shares were sold at a weighted average price of $15.00 per share, with individual trades executed in a narrow range between $15.00 and $15.01. The filing notes that the transaction was carried out under a Rule 10b5‑1 trading plan that had been adopted on September 23, 2025, indicating it was pre-arranged rather than an ad hoc sale.
Oscar Health, Inc. officer reports small share sale under 10b5‑1 plan. The company’s Chief Legal Officer reported selling 1,852 shares of Class A common stock on 12/02/2025 at a weighted average price of $16.59 per share. The transaction was coded as a sale and was executed under a pre-arranged Rule 10b5-1 instruction letter entered into on August 8, 2025 to cover tax withholding obligations from vesting equity awards. After this sale, the officer beneficially owns 179,241 shares of Oscar Health, Inc. common stock directly.
Oscar Health, Inc. reported an insider stock transaction by a director and its President of Technology & CTO. On 12/02/2025, the executive sold 23,965 shares of Class A common stock in an open-market transaction coded as a sale at a weighted average price of $16.59 per share. Following this transaction, the executive directly owned 477,183 shares of Class A common stock.
The company notes that the sale was made under a Rule 10b5-1 instruction letter entered into on August 8, 2025, and was intended to satisfy the reporting person's tax withholding obligations arising from the vesting of previously granted equity awards. The reported sale occurred through multiple trades at prices ranging from $16.37 to $16.78 per share.
Oscar Health, Inc. reported an insider stock sale by a senior officer. On 12/02/2025, the President of Oscar Insurance sold 7,338 shares of Class A common stock at a weighted average price of $16.59 per share. After this transaction, the reporting person beneficially owns 172,527 shares directly.
The sale was made under a pre-arranged Rule 10b5-1 trading instruction entered into on August 8, 2025 and was intended to cover the officer’s tax withholding obligations related to the vesting of previously granted equity awards. The shares were sold in multiple trades at prices ranging from $16.37 to $16.78.
Oscar Health, Inc. reported that its Chief Financial Officer sold 25,135 shares of Class A common stock on 12/02/2025 at a weighted average price of $16.59 per share. The sale was made under a pre-arranged Rule 10b5-1 instruction letter entered into on August 8, 2025, to cover the executive’s tax withholding obligations related to the vesting of previously granted equity awards.
Following this transaction, the CFO beneficially owns 1,351,034 shares of Oscar Health Class A common stock, held directly.
Oscar Health, Inc. (OSCR) reported an insider stock sale by its Chief Accounting Officer. On 12/02/2025, the officer sold 4,149 shares of Class A common stock in an open-market transaction coded as a sale. The weighted average price was $16.59 per share, with individual trades occurring between $16.37 and $16.78.
After this transaction, the officer beneficially owned 203,450 shares of Oscar Health Class A common stock. The sale was carried out under a Rule 10b5-1 instruction letter dated August 8, 2025, and was intended to satisfy tax withholding obligations upon the vesting of previously granted equity awards.
Oscar Health (OSCR) reported insider activity by its President of Technology & CTO, who also serves as a director. On 11/11/2025 and 11/12/2025, the insider exercised stock options at $6.36 per share and converted Class B into Class A, then sold shares to cover the cost of exercise and tax withholding.
The insider sold 286,182 Class A shares at a weighted average price of $15.27 on 11/11/2025 and 105,300 shares at a weighted average price of $15.05 on 11/12/2025. Following the transactions, the insider directly owned 501,148 Class A shares. The option referenced is fully vested and expires on December 7, 2025. The filing also lists indirect holdings of Class A shares held by related trusts.